Ching‐Chan Lin
Impact in
- Otorhinolaryngology top 10%
- Head and Neck Cancer Studies
- Hematology top 10%
- Acute Myeloid Leukemia Research
Papers in
-
- Head and Neck Cancer Studies 6
-
- Acute Myeloid Leukemia Research 4
- Co-authors
- Chen-Yuan Lin (15 shared papers)Ching-Yun Hsieh (14 shared papers)Su‐Peng Yeh (12 shared papers)Chang‐Fang Chiu (12 shared papers)Li‐Yuan Bai (10 shared papers)Wei‐Chao Chang (6 shared papers)Yuh‐Pyng Sher (7 shared papers)Mao‐Wang Ho (2 shared papers)
- Journals
- Scientific Reports (3 papers)BMC Cancer (2 papers)Leukemia Research (2 papers)Molecular Oncology (2 papers)Supportive Care in Cancer (1 paper)
- Partner nations
- TaiwanChinaUnited States
In The Last Decade
Ching‐Chan Lin
35 papers receiving 569 citations
Peers
Comparison fields: 5 of 59
- Otorhinolaryngology 56
- Hematology 115
- Cancer Research 61
- Oncology 80
- Infectious Diseases 57
Countries citing papers authored by Ching‐Chan Lin
This map shows the geographic impact of Ching‐Chan Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ching‐Chan Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ching‐Chan Lin more than expected).
Fields of papers citing papers by Ching‐Chan Lin
This network shows the impact of papers produced by Ching‐Chan Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ching‐Chan Lin. The network helps show where Ching‐Chan Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Ching‐Chan Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 72 | |
| 2 | 2018 | 54 | |
| 3 | 2017 | 47 | |
| 4 | 2022 | 42 | |
| 5 | 2017 | 41 | |
| 6 | 2012 | 39 | |
| 7 | 2020 | 33 | |
| 8 | 2017 | 29 | |
| 9 | 2024 | 20 | |
| 10 | 2024 | 19 | |
| 11 | 2020 | 17 | |
| 12 | 2014 | 12 | |
| 13 | Resveratrol-mediated ADAM9 degradation decreases cancer progression and provides synergistic effects in combination with chemotherapy. | 2020 | 12 |
| 14 | 2022 | 12 | |
| 15 | 2018 | 11 | |
| 16 | 2023 | 11 | |
| 17 | 2015 | 9 | |
| 18 | 2022 | 9 | |
| 19 | 2023 | 9 | |
| 20 | 2022 | 8 |
About Ching‐Chan Lin
Ching‐Chan Lin is a scholar working on Otorhinolaryngology, Hematology, Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 35 papers that have together received 577 indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (6 papers), Acute Myeloid Leukemia Research (4 papers), Lung Cancer Treatments and Mutations (3 papers), Bladder and Urothelial Cancer Treatments (3 papers), Protease and Inhibitor Mechanisms (3 papers), Antifungal resistance and susceptibility (2 papers), Pancreatic and Hepatic Oncology Research (2 papers) and Digital Imaging for Blood Diseases (2 papers). The work is most often cited by research in Otorhinolaryngology (56 citations), Hematology (115 citations), Cancer Research (61 citations), Oncology (80 citations) and Infectious Diseases (57 citations). Ching‐Chan Lin has collaborated with scholars based in Taiwan, China and United States. Frequent co-authors include Chen-Yuan Lin, Ching-Yun Hsieh, Su‐Peng Yeh, Chang‐Fang Chiu, Li‐Yuan Bai, Wei‐Chao Chang, Yuh‐Pyng Sher, Mao‐Wang Ho, Yu‐Sen Lin and Chi‐Rei Yang. Their work appears in journals such as Scientific Reports, BMC Cancer, Leukemia Research, Molecular Oncology and Supportive Care in Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.